Stock TTH TRANSITION THERAPEUTICS INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News Transition Therapeutics Inc

Equities

TTH

CA8937162094

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Transition Therapeutics : Announces Special Shareholder Meeting Voting Results Including Shareholder Approval of the Plan of Arrangement with OPKO Health, Inc.
PR
Transition Therapeutics : Receives Notification From NASDAQ
PR
Transition Therapeutics : Announces Third Quarter Fiscal 2016 Financial Results
PR
Transition Therapeutics to Hold Conference Call on Third Quarter Fiscal 2016 Financial Results on Wednesday, May 11th, at 4:30 P.M. EST
PR
Transition Therapeutics : Provides Update on Type 2 Diabetes Drug Candidate TT401
PR
Transition Therapeutics : Receives Notification From NASDAQ
PR
Transition Therapeutics : to Present at the 36th Annual Cowen Healthcare Conference
PR
Transition Therapeutics : Announces Second Quarter Fiscal 2016 Financial Results
PR
Transition Therapeutics : to Hold Conference Call on Second Quarter Fiscal 2016 Financial Results on Tuesday, February 9th, at 4:30 P.M. EST
PR
Transition Therapeutics : Announces Top Line Phase 2 Clinical Study Results of Diabetes Drug Candidate TT401
PR
Transition Therapeutics : Announces Annual General Meeting Voting Results
PR
Transition Therapeutics : to Host Investor Day November 23 in New York
PR
Transition Therapeutics : Announces First Quarter Fiscal 2016 Financial Results
PR
Transition Therapeutics : to Hold Conference Call on First Quarter Fiscal 2016 Financial Results on Tuesday, November 10th, at 4:30 P.M. EST
PR
Transition Therapeutics : Announces Presentation of ELND005 Phase 2/3 Clinical Study Results at Clinical Trials in Alzheimer's Disease (CTAD) Conference
PR
Transition Therapeutics : Announces Results of Data Analysis from ELND005 Phase 2/3 Clinical Study in Agitation and Aggression in Alzheimer's Disease Patients
PR
Transition Therapeutics : Announces Fiscal 2015 Financial Results
PR
Transition Therapeutics : to Hold Conference Call on Fiscal 2015 Financial Results on Tuesday, September 15th, at 4:30 P.M. EST
PR
Transition Therapeutics : to Present at the Canaccord Genuity 35th Annual Growth Conference
PR
Transition Therapeutics : Announces Results of Clinical Study of ELND005 in Agitation and Aggression in Patients with Alzheimer's Disease
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TTH Stock
  4. News Transition Therapeutics Inc